Skip to main content
Clinical Trials/NL-OMON48886
NL-OMON48886
Completed
N/A

Quality of life, cognitive function, and physical fitness of patients surviving more than 2 years after immune checkpoint inhibitor therapy - Quality of life and physical fitness after immune checkpoint inhibitors

niversitair Medisch Centrum Groningen0 sites195 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
195
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with melanoma, NSCLC or urogenital cancers \*2 years since treatment
  • with at least one cycle of immune checkpoint inhibitor (CTLA\-4 inhibitor,
  • PD(L)\-1 inhibitor, or both) within the Department of Medical Oncology or
  • Pulmonary Oncology of the UMCG.
  • 2\. age \*18 years at time of immune checkpoint inhibitor treatment
  • 3\. all previous or subsequent therapies allowed, including (brain) irradiation,
  • surgery for metastases, chemotherapy, and targeted therapy provided stable
  • clinical situation at time of inclusion

Exclusion Criteria

  • 1\. switch of systemic therapy or local antitumor intervention (surgery,
  • radiotherapy) during last 2 months
  • 2\. inability to understand or abide to the study protocol
  • 3\. debilitating psychiatric illness
  • 4\. previous treatment for malignancy other than melanoma (excluding
  • non\-melanoma skin cancer, cervical intra\-epithelial neoplasia (CIN) or
  • carcinoma in situ of breast)

Outcomes

Primary Outcomes

Not specified

Similar Trials